NCT05853471UNKNOWNanonymous

Evaluation of [18F]MC225-PET to Measure P-glycoprotein Function in Neurodegenerative Disease

Sponsor

Source record

University Medical Center Groningen

Phase

Source record

PHASE1

Modality

AI-normalized

small molecule

Target

AI-normalized

[18F]MC225

Indication / condition

AI-normalized

Neurodegenerative Diseases

Intervention

Source record

[18F]MC225

Related intelligence directories

Indication directory: Neurodegenerative Diseases Modality directory: small molecule Target directory: [18F]MC225

Source & freshness

Source record

NCT ID

NCT05853471

Original source

ClinicalTrials.gov

Source last updated

Detailed source ingestion pending.

Ingested at

Jul 24, 2026

Internal sync

Jul 24, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT05853471

Title

Evaluation of [18F]MC225-PET to Measure P-glycoprotein Function in Neurodegenerative Disease

Sponsor

University Medical Center Groningen

Status

UNKNOWN

Phase

PHASE1

Condition raw

Neurodegenerative Diseases, Alzheimer Disease, Parkinson Disease, Mild Cognitive Impairment

Condition normalized

Neurodegenerative Diseases, Alzheimer Disease, Parkinson Disease, Mild Cognitive Impairment

Modality raw

small molecule

Modality normalized

small molecule

Target raw

[18F]MC225

Target normalized

[18F]MC225

Interventions

[18F]MC225

Public preview

Source record

Evaluation of [18F]MC225-PET to Measure P-glycoprotein Function in Neurodegenerative Disease is a PHASE1 clinical asset sponsored by University Medical Center Groningen in Neurodegenerative Diseases, Alzheimer Disease, Parkinson Disease, Mild Cognitive Impairment. SEO and diligence focus: [18F]MC225, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Evaluation of [18F]MC225-PET to Measure P-glycoprotein Function in Neurodegenerative Disease

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jul 28, 2026

Report code

NCT05853471-Jul 28, 2026

NCT ID

NCT05853471

Status

UNKNOWN

Phase

PHASE1

Sponsor

University Medical Center Groningen

Executive brief

Investment-Ready Snapshot

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedDetailed source ingestion pending.

Internal syncJul 24, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT05853471

Indication

Neurodegenerative Diseases

Modality

small molecule

Target

[18F]MC225

Intervention

[18F]MC225

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.